RISK OF SARS TRANSMISSION TO PERSONS IN CLOSE CONTACT WITH DISCHARGED PATIENTS
To the Editor:
Within a short period of time, severe acute respiratory syndrome (SARS) has become a major global health hazard. Despite the 4% mortality associated with SARS (1), many patients make good recovery and are discharged home after treatment. However, these patients may continue to carry the virus and there is a risk of transmission to other people.
In March 2003, there was a major outbreak of SARS in Hong Kong. Most patients were treated with ribavirin and steroids. Because of lack of knowledge about the disease at the time, patients were kept in hospital until 3 weeks after the onset of illness. Other discharge criteria included being afebrile for at least 4 days, chest consolidation reduced by 25%, and no need for supplementary oxygen. Discharged patients were advised to stay home for 1 week and to wear a mask at home. Because coronavirus may be shed in feces, toilet hygiene was also emphasized.
As of May 24, 2003, 462 SARS patients had been treated in one of three hospitals in Hong Kong: Prince of Wales Hospital, Alice Ho Miu Ling Nethersole Hospital, and Tai Po Hospital. Of these patients, 277 had been discharged home for at least 1 week. We interviewed them by telephone to determine if any of their household members had been infected after their discharge. The majority of the discharged patients (88% [n ϭ 244]) lived with family members. Among the 520 household members of these 244 patients, only 1 was admitted to hospital with SARS. This patient's mother had been discharged on March 28 and the patient had started to have a fever on March 29. This patient had mental retardation and required assistance for daily activities. His mother admitted that she did not always wear a mask at home while looking after the patient after her discharge.
It is difficult to determine if the patient got the infection from his mother because the incubation period (1 day) seems short. Nevertheless, these data suggest that with proper treatment and use of protective masks, the risk of transmission from recovered patients to close contacts is very low. The World Health Organization has recently adopted a less stringent discharge policy that does not require patients to be isolated for 21 days from illness onset (2) 
SUCCESSFUL ANTIMICROBIAL CHEMOTHERAPY FOR NOCARDIA ASTEROIDES PROSTHETIC VALVE ENDOCARDITIS
Nocardia causes several distinctive syndromes in both immunocom-petent and immunocompromised hosts (1). Although widespread dissemination of the organism occurs and may affect any organ, endocarditis due to infection by Nocardia species is rare. To our knowledge, only 8 cases of nocardial endocarditis, mostly treated with valve replacement, have been reported in the English literature (2-8). We report a patient with prosthetic valve endocarditis due to Nocardia asteroides, who was treated successfully with antimicrobial chemotherapy instead of valve replacement.
A 61-year-old woman with severe calcific aortic valve disease underwent valve replacement with a St. Jude metallic valve in October 2000. The early postoperative course was uneventful. Three weeks after the operation, fever developed and she was treated empirically with vancomycin, amikacin, and rifampin for 2 weeks. The fever persisted and she was transferred to our medical department. The antibiotics were discontinued and blood cultures were obtained. Physical examination revealed a temperature of 39°C, a heart rate of 100 beats per minute, a blood pressure of 130/80 mm Hg, clear prosthetic valve sounds, a mild systolic ejection murmur at the aortic valve, and no hepatosplenomegaly. The second day of hospitalization, splinter hemorrhages and a painful nodular lesion (Osler node) appeared on the last phalanx of the right, middle finger, and there was subconjuctival hemorrhage in the right eye. Two days later, five papular lesions (0.3 to 0.5 cm in diameter) appeared on both forearms. Laboratory evaluation revealed the following: hemoglobin, 8.5 g/dL; white blood cell count, 5.15 ϫ 10 9 /L; platelet count, 196 ϫ 10 9 /L; erythrocyte sedimentation rate, 45 mm/h; rheumatoid factor, 120 IU/mL; and normal urine. Chest radiography, and computed tomography of the brain, chest, and abdomen, did not reveal any abnormalities. Both transthoracic and Letters to the Editor
